10x Genomics is trading 4.91% lower at $69.51 in pre-market on October 15, with no clear company-specific announcement explaining the decline; broader technology weakness offers a plausible backdrop.
- It closed at $73.10 on October 14.
- Reuters reported hotter-than-expected inflation intensified expectations of higher rates, weighing on technology shares. Nasdaq futures fell more than 1% amid concerns about financing AI investment. This is market context, not a confirmed company-specific catalyst.